OncoTargets and Therapy (Sep 2021)
MicroRNA-652 Suppresses Malignant Phenotypes in Glioblastoma Multiforme via FOXK1-Mediated AKT/mTOR Signaling Pathway [Retraction]
Abstract
Yang H, Song Z, Wu X, Wu Y, Liu C. Onco Targets Ther. 2019;12:5563–5575. The Editor and Publisher of OncoTargets and Therapy wish to retract the published article. Concerns were raised over alleged image duplication in Figures 2D and 8B with similar images from unrelated articles, specifically: Figure 2D, panel T98 agomiR-652 appears to have been duplicated with a similar image in Figure 6C from Cheng et al, (https://doi.org/10.2147/OTT.S218876). Figure 8B appears to have been duplicated with similar images in Figure 7A from Ren et al, 2019 (http://www.ajcr.us/files/ajcr0088433.pdf). The authors did not respond to our queries and the Editor determined the findings of the study were no longer valid and advised for the article to be retracted. Our decision-making was informed by our policy on publishing ethics and integrity and the COPE guidelines on retraction. The retracted article will remain online to maintain the scholarly record, but it will be digitally watermarked on each page as “Retracted”. This retraction relates to this paper
